POLYNEUROPATHIES
Clinical trials for POLYNEUROPATHIES explained in plain language.
Never miss a new study
Get alerted when new POLYNEUROPATHIES trials appear
Sign up with your email to follow new studies for POLYNEUROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing shot aims to halt rare nerve disease in phase 3 trial
Disease control Recruiting nowThis phase 3 trial tests a single dose of NTLA-2001, a gene-editing therapy, in 60 adults with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare genetic disease that damages nerves. Participants are randomly assigned to receive either the active treatmen…
Matched conditions: POLYNEUROPATHIES
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New ultrasound and DNA test could revolutionize leprosy diagnosis
Diagnosis Recruiting nowThis study is testing whether a new approach—using ultrasound to guide a tiny needle to collect fluid near the ulnar nerve, then analyzing it for leprosy bacteria DNA—can more accurately diagnose leprosy and confirm when it's cured. Researchers will follow 108 participants for on…
Matched conditions: POLYNEUROPATHIES
Phase: NA • Sponsor: University of Brasilia • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New drug aims to stop rare genetic disease before it strikes
Prevention Recruiting nowThis phase 3 trial tests whether acoramidis can prevent or delay transthyretin amyloidosis (ATTR) in 587 adults who carry a faulty gene but have no symptoms yet. ATTR causes sticky plaques to build up in the heart and nerves, leading to heart failure and nerve damage. Acoramidis …
Matched conditions: POLYNEUROPATHIES
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Ultrasound to reveal hidden bleeding after EMG in blood thinner users
Knowledge-focused Recruiting nowThis study is checking whether a common nerve test called needle EMG causes muscle bleeding in people taking blood thinners (DOACs). About 30 minutes after the test, researchers will use ultrasound to look for any small bleeds in the muscles where the needle went in. The goal is …
Matched conditions: POLYNEUROPATHIES
Sponsor: Masaryk University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:36 UTC